EXPERT REACTION: Caffeine during pregnancy may not be a good idea

Embargoed until: Publicly released:
Peer-reviewed: This work was reviewed and scrutinised by relevant independent experts.

Observational study: A study in which the subject is observed to see if there is a relationship between two or more things (eg: the consumption of diet drinks and obesity). Observational studies cannot prove that one thing causes another, only that they are linked.

People: This is a study based on research using people.

Women who are pregnant or trying for a baby should consider avoiding caffeine, according to international researchers who looked at 37 observational studies about the effects of caffeine on six negative pregnancy outcomes: miscarriage, stillbirth, childhood leukaemia, low birth weight, childhood obesity and preterm birth. A total of 42 separate findings were reported in 37 studies, and of these, 32 found that caffeine significantly increased the risk of poor pregnancy outcomes, while 10 found no or inconclusive associations. While these studies cannot establish cause-and-effect, the authors say the results suggest the current health recommendations around caffeine during pregnancy require “radical revision”.

Journal/conference: BMJ Evidence Based Medicine

Link to research (DOI): 10.1136/bmjebm-2020-111432

Organisation/s: The University of Adelaide, The University of Melbourne, University of Canberra, The University of Newcastle, The University of Queensland, Reykjavik University, Iceland

Funder: None declared

Media release

From: The BMJ

No safe level of caffeine consumption for pregnant women and would-be mothers

Women who are pregnant or trying for a baby should consider avoiding caffeine, researchers say

Women who are pregnant or trying to conceive should be advised to avoid caffeine because the evidence suggests that maternal caffeine consumption is associated with negative pregnancy outcomes and that there is no safe level of consumption, finds an analysis of observational studies published in BMJ Evidence Based Medicine.

Caffeine is probably the most widely consumed psychoactive substance in history, and many people, including pregnant women consume it on a daily basis.

Pregnant women have been advised that consuming a small amount of caffeine daily will not harm their baby. The UK NHS, the American College of Obstetricians and Gynecologists, the Dietary Guidelines for Americans and the European Food Safety Authority (EFSA) set this level at 200 mg caffeine, which approximates to roughly two cups of moderate-strength coffee per day.

This study undertook a review of current evidence on caffeine-related pregnancy outcomes, to determine whether the recommended safe level of consumption for pregnant women is soundly based.

Through database searches, Professor Jack James, of Reykjavik University, Iceland, identified 1,261 English language peer-reviewed articles linking caffeine and caffeinated beverages to pregnancy outcomes.

These were whittled down to 48 original observational studies and meta-analyses published in the past two decades reporting results for one or more of six major negative pregnancy outcomes: miscarriage, stillbirth, low birth weight and/or small for gestational age, preterm birth, childhood acute leukaemia, and childhood overweight and obesity.

A total of 42 separate findings were reported in 37 observational studies; of these 32 found that caffeine significantly increased risk of adverse pregnancy outcomes and 10 found no or inconclusive associations. Caffeine-related risk was reported with moderate to high levels of consistency for all pregnancy outcomes except preterm birth.

Eleven studies reported on the findings of 17 meta-analyses, and in 14 of these maternal caffeine consumption was associated with increased risk for four adverse outcomes: miscarriage, stillbirth, low birth weight and/or small for gestational age, and childhood acute leukaemia. The three remaining meta-analyses did not find an association between maternal caffeine consumption and preterm birth.

No meta-analyses looked at the association between maternal caffeine consumption and childhood overweight and obesity, but four of five observational studies reported significant associations.

This is an observational study, so can’t establish causation, and the author points out that the results could be impacted by other confounding factors, such as recall of caffeine consumption, maternal cigarette smoking and most importantly pregnancy symptoms. Pregnancy symptoms such as nausea and vomiting in early pregnancy are predictive of a healthy pregnancy and women who experience them are likely to reduce their caffeine intake.

But he adds that the dose-responsive nature of the associations between caffeine and adverse pregnancy outcomes, and the fact some studies found no threshold below which negative outcomes were absent, supports likely causation rather than mere association.

Professor James concludes that there is “substantial cumulative evidence” of an association between maternal caffeine consumption and diverse negative pregnancy outcomes, specifically miscarriage, stillbirth, low birth weight and/or small for gestational age, childhood acute leukaemia and childhood overweight and obesity, but not preterm birth.

As a result, he adds, current health recommendations concerning caffeine consumption during pregnancy are in need of “radical revision."

"Specifically, the cumulative scientific evidence supports pregnant women and women contemplating pregnancy being advised to avoid caffeine,” he says. [Ends]

Notes for editors Research: Maternal caffeine consumption and pregnancy outcomes: a narrative review with implications for advice to mothers and mothers-to-be doi 10.1136/bmjebm-2020-111432
Journal: BMJ Evidence Based Medicine

Funding: None declared

Attachments:

Note: Not all attachments are visible to the general public

  • The BMJ
    Web page
    The URL will go live after the embargo ends.

Expert Reaction

These comments have been collated by the Science Media Centre to provide a variety of expert perspectives on this issue. Feel free to use these quotes in your stories. Views expressed are the personal opinions of the experts named. They do not represent the views of the SMC or any other organisation unless specifically stated.

Professor Michael Davies is a reproductive epidemiologist from the Robinson Research Institute at the University of Adelaide

I have 6 points to make:

  1. The press release is potentially alarmist as the study extrapolates beyond available data.
     
    The statement that there is “No lower threshold” is not the same as no evidence of harm.  There is no clear evidence of harm at low levels of tea and coffee consumption as there are no reliable data, due to low observed risks.
     
  2. Maternal genes that control the metabolism of caffeine should be associated with adverse outcomes as they alter maternal and fetal exposure, but they are not. This implies a different unmeasured factor is involved.
     
  3. The results between coffee and tea are contradictory, indeed opposing, for leukaemia where tea consumption is protective. 
     
  4. The author has previously acknowledged that coffee and tea drinkers have lower all-cause mortality, but they attributes this to the positive non-caffeine properties of coffee and tea.
     
  5. Extreme levels of exposure to, or consumption of, any substance may well adversely alter fetal development. 
     
  6. Please, moderation in all matters to protect the welfare of mother and child. 
Last updated: 25 Aug 2020 3:05pm
Declared conflicts of interest:
None declared.
Clare Collins is a Laureate Professor in Nutrition and Dietetics at the University of Newcastle and Co-Director of the Food and Nutrition Research Program at the Hunter Medical Research Institute

This review of research on the relationship between pregnancy outcomes and total caffeine intake from tea, coffee, cola and energy drinks provides evidence that women should avoid caffeine in pregnancy. Results also warrant a review of guidelines on the amount of caffeine deemed safe for regular consumption by pregnant women. The author has summarised data from 37 separate observational studies and 17 meta-analyses published from 1998 to 2019. Overall results show substantial consistency across findings, with 32 studies reporting a higher risk for adverse pregnancy outcomes with higher caffeine intakes, while 10 studies reported equivocal results or no association. Of the meta-analyses, 14 found a risk of harm for higher maternal caffeine intakes, four meta-analyses reported greater risk of miscarriage, two meta-analyses reported higher risks for still-birth, five meta-analyses reported greater risk for low birth weight or small for gestational age and three meta-analyses reported greater risk for childhood leukaemia. The three meta-analyses conducted for pre-term birth did not consistently indicate higher risk. 

While you could discount these results because they are from observational studies and hence they cannot infer causation; or because of methodological weaknesses and limitations inherent in observational studies; or because case-control studies are more prone to recall bias, the finding of a dose-response relationship cannot be ignored. This means that the risk of adverse pregnancy outcomes increases in a stepwise manner as caffeine intakes increase and this should raise an alarm.

The reality is that it is not ethical to conduct randomised trials that administer caffeine in a double-blind manner to see whether caffeine causes harm in human pregnancy. Together with research from animal studies, which has shown that caffeine can disrupt embryo transport, development, implantation, placental function and increase pregnancy complications, this review should trigger greater caution in regard to caffeine in human pregnancy.

This review is also timely because intakes of barista-style coffee, which has a higher caffeine content compared to freeze-dried coffee powders, as well as energy drinks, have increased in many countries in recent decades. Women may be unaware of what their total caffeine intakes are relative to the 300 milligrams per day commonly recommended as an upper limit. Results from further research may help clarify whether small amounts of caffeine are associated with harm.

Last updated: 24 Aug 2020 3:40pm
Declared conflicts of interest:
None declared.

Dr Cathy Knight-Agarwal is a Clinical Assistant Professor of Nutrition and Dietetics at the School of Clinical Sciences, University of Canberra

Caffeine is found in a number of food products that may be consumed by women in pregnancy such as coffee (both instant and espresso), tea, cola drinks, energy drinks and chocolate. Currently the Food Standards Australia and New Zealand recommend pregnant and breastfeeding women to consume no more than 200mg of caffeine each day from all sources (for example espresso on average contains 145mg caffeine per 50ml cup and milk chocolate 10mg caffeine per 50g bar).

The research presented here is observational in nature, so cannot establish causation. No study design can account for confounding factors (for example what the true intake of caffeine may be) in the way that a randomised control trial can. However, it would be unethical to conduct such a trial with caffeine in pregnancy as the exact level of intake to cause harm to the growing baby is still largely unknown. In addition, the level of intake to cause harm may be different from woman to woman as well as being dependent on the stage of pregnancy as well as health status.

Despite its observational design, the current study provides some compelling evidence to ponder. If pregnant women cut out caffeinated products from their diet would this compromise their nutritional status and the answer is a big no. Therefore, from my perspective the only benefit of consuming such products is perhaps the psychological pleasure they induce – which is all very well and good but is this enough of a reason not to cease consumption during pregnancy?

The Australian and New Zealand Governments advise women not to consume alcohol during pregnancy as there is no established level of safety. Perhaps caffeine intake advice during pregnancy should mirror that of alcohol? This is a topic for further debate.

Last updated: 24 Aug 2020 4:09pm
Declared conflicts of interest:
None declared.
Gino Pecoraro OAM is Associate Professor of Obstetrics and Gynaecology at the University of Queensland and President of the National Association of Specialist Obstetricians and Gynaecologists (NASOG). He is also a practising obstetrician and gynaecologist in private practice in Brisbane.

Consumption of caffeine by pregnant women is exceptionally common with over 80 per cent of American women reporting daily caffeine use and over 90 per cent in some European centres. Therefore, any study  looking at adverse effects associated with consumption of caffeine during pregnancy is important and any potential new recommendations will affect a large number of women.

The significant limitations in the design of the paper, mean that while it is worthwhile discussing caffeine consumption with pregnant women, I’m not convinced that a total ban is warranted at this time.

This paper is a review of 48 previously published observational studies and meta-analyses. Its findings were not unanimous.

It is not a new piece of research specifically designed to answer the question of whether caffeine causes harm and what if any, level of consumption is safe.

Three quarters of the studies looked out, found caffeine exposure during pregnancy was associated with adverse outcomes while one quarter found no or inconclusive associations. 

The adverse events associated with caffeine consumption include miscarriage, stillbirth low birth weight and small the gestation will age as well as childhood acute leukaemia and childhood obesity. 

While three quarters of the included studies found support for association with low birth weight and childhood obesity, only  half of the four preterm birth studies found an association while another half showed no association.
The comments around leukaemia were based on six studies, only half of which reported association and another third reporting adverse effects when smoking was added to caffeine consumption. 

There was no association with preterm delivery and no study reported a threshold below which harm was absent.

Last updated: 24 Aug 2020 3:32pm
Declared conflicts of interest:
None declared.
Associate Professor Luke Grzeskowiak is a clinical pharmacist and The Hospital Research Foundation Mid-Career Research Fellow at Flinders University and SAHMRI

The author's conclusion that all pregnant women and women contemplating pregnancy should avoid caffeine is overly alarmist and inconsistent with the evidence.

This report actually provides no new evidence on the topic, instead providing just one individual’s different perspective on existing evidence. It is true that previous studies have not confirmed a safe limit of caffeine intake during pregnancy, but this is very different to concluding that all levels of caffeine intake are harmful.

In fact, previous studies are relatively consistent in showing that small to moderate amounts of caffeine (< 200 – 300 mg day) are unlikely to harm the pregnancy. The main associations, and therefore concerns, with negative pregnancy outcomes relate to women consuming high amounts of caffeine each day.

Therefore, the current recommendations are and remain that women should limit caffeine intake where possible to less than 200-300 mg daily, but this is out of an abundance of caution rather than high-quality evidence.

There are so many dos and don'ts associated with pregnancy and the last thing we need is to cause unnecessary anxiety. At the end of the day, women should be reassured that caffeine can be consumed in moderation during pregnancy.

Last updated: 24 Aug 2020 3:42pm
Declared conflicts of interest:
None declared.

News for:

International
NSW
VIC
QLD
SA
ACT

Media contact details for this story are only visible to registered journalists.